High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer

High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer

Abstract Background α3β1 integrin is a promising cancer biomarker and drug target. We previously identified a 9-amino-acid cyclic peptide LXY30 for detecting α3β1 integrin on the surface of live tumor cells. This study was undertaken to characterize LXY30 in the detection, cellular function, imaging...

Full description

Bibliographic Details
Main Authors: Wenwu Xiao, Weijie Ma, Sixi Wei, Qianping Li, Ruiwu Liu, Randy P. Carney, Kevin Yang, Joyce Lee, Alan Nyugen, Ken Y. Yoneda, Kit S. Lam, Tianhong Li
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Journal of Hematology & Oncology
Subjects:
Cancer-targeting peptide
α3β1 integrin
Non-small cell lung cancer
Exosomes
In vivo imaging
Patient-derived xenograft
Online Access:http://link.springer.com/article/10.1186/s13045-019-0740-7

Internet

http://link.springer.com/article/10.1186/s13045-019-0740-7

Similar Items